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ADH = antidiuretic hormone; Na+ = sodium; Posm = plasma osmolality 
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PROFILE
Definition
Hyponatremia is defined as a plasma sodium (Na+) concentration < 140 mEq/L in dogs
and 150 mEq/L in cats.1 Because plasma Na+ concentration is the main determinant of
plasma osmolality (Posm), hyponatremia usually reflects hypoosmolality. Since the kid-
neys are highly efficient in excreting water, hypoosmolality almost always implies a
defect in renal water excretion and excess of water in the body due to one of the 
following mechanisms:
 Impaired diluting ability in the loop of Henle and distal tubule (volume depletion,
renal failure, diuretics)
 Increased collecting-tubule permeability due to the presence of antidiuretic hormone
(ADH) (effective circulating volume depletion, inappropriate ADH secretion, pain,
adrenal insufficiency, or hypothyroidism)
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Na+ concentration: Reflects the
content of sodium relative to
the volume of water in the
body, not total sodium content.
Therefore, hyponatremic
patients can have decreased,
increased, or normal total
sodium content. 
Na+ content: Reflects the total
amount of sodium in
extracellular fluid and is
calculated by multiplying the
concentration of sodium by the
volume of extracellular fluid. 
Osmolality: Concentration of
osmotically active particles in a
solution. 
• Plasma osmolality (Posm) is
the main determinant of
water distribution in the body.
Because water can move
freely across almost all cell
membranes, the osmolalities
of intracellular and
extracellular fluids are the
same.  
• Normal plasma osmolality
ranges from 290 to 310
mOsm/kg in dogs and 290 to
330 mOsm/kg in cats.
Posm = 2 × Na+ + glucose/18 +
BUN/2.8
• The contributions of glucose
and BUN to Posm are
normally small, except in
diabetes mellitus and renal
failure. Urea can freely cross
cell membranes; its
contribution to Posm can be
excluded:
Effective Posm = 
measured Posm – BUN/2.8
Tonicity: Osmotic pressure of a
solution. It determines the
ability of a solution to move
across a membrane.
Na+ expressed as mEq/L; glucose
expressed as mg/dL; BUN expressed
as mg/dL
Pathophysiology: Why is there too
much water?
Body fluid balance depends largely on the
interrelationship of salt and water. Although
effective circulating volume is largely con-
trolled by sodium balance, maintaining osmo-
lality depends on regulation of water balance
(Table 1).
 Na+ balance: Several sensors in the body
detect changes in extracellular fluid vol-
ume (which is largely determined by total
sodium content). 
 Water balance: Although extracellular fluid
and intracellular fluid have different com-
positions, they must maintain the same
tonicity. The balance is sensed and con-
trolled by thirst and osmoregulation sys-
tems. Osmoreceptors of the hypothalamus
and neurohypophysis are sensitive to alter-
ations in plasma osmolality and hydro-
static pressure; they respond to plasma
hypertonicity by increasing thirst and
ADH secretion. When the osmolality is
low, ADH secretion is suppressed and
urine is diluted.
Signs
Depending on the severity of hyponatremia,
patients may have no clinical signs or present
with varying degrees of neurologic signs.
Cerebral edema and water intoxication occur
as serum sodium concentration decreases, and
the osmotic gradient that develops makes
water move into the brain. Typical neurologic
signs include the following:
 Lethargy
 Irritability
 Nausea/vomiting
 Mental dullness or depression
 Stupor
 Seizures
 Coma
Clinical signs related to the underlying cause
of the hyponatremia may also be present:
 Tachycardia
 Hypotension
 Prolonged capillary refill time
 Weakness
 Ascites
 Edema
Signalment
Hyponatremia is a common electrolyte disor-
der occurring in a broad spectrum of patients,
from ones without clinical signs to the criti-
cally ill.  
Causes
The principal causes of hyponatremia are:
 Disorders associated with impaired renal
water excretion (more common):
 Volume depletion 
• Extrarenal losses: Gastrointestinal dis-
orders (vomiting, diarrhea); third-space
disorders (pancreatitis, peritonitis)
• Renal losses: Diuretic therapy (thiazide),
osmotic diuresis (glucose, mannitol),
advanced renal failure (decreased
glomerular filtration rate)
• Edematous states: Congestive heart fail-
ure, liver disease, nephrotic syndrome
 ADH excess:
• Inappropriate ADH secretion
(SIADH)
• Mineralocorticoid deficiency
• Hypothyroidism
 Disorders associated with normal renal
water excretion:
 Excessive water intake (primary 
polydipsia) 
 Reset osmostat syndrome
 Rapid infusion of hypotonic fluids
 Disorders associated with pseudohypona-
tremia or translocational hyponatremia:
 Hyperlipidemia
 Hyperproteinemia
 Hyperglycemia
Risk Factors
There are currently no reports of risk factors
for hyponatremia in dogs and cats, but serum
Na+ concentration should be measured in
small animals with:
 Suspected hypoadrenocorticism
 Vomiting and diarrhea
 Diuretic use
 Effusive disorders
 Polyuria and polydipsia
 Abnormal mental status or behavior
 Seizures
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DIAGNOSIS
Definitive Diagnosis
 Hyponatremia: Serum Na+ concentration 
< 140 mEq/L in dogs or < 150 mEq/L in
cats.
 Neurologic signs are not usually seen unless
Na+ concentrations are < 120 mEq/L in dogs
or < 130 mEq/L in cats. However, the devel-
opment of neurologic signs is also related to
rapidity of onset of hyponatremia. In chronic
disorders, the signs are more subtle and non-
specific because the brain has had enough
time to adapt to plasma hypotonicity.
Laboratory Findings & Imaging
 Laboratory data should ideally include plasma
osmolality, Na+, potassium, chloride, bicarbon-
ate, BUN, and glucose concentrations, and,
where necessary, urine Na+ concentration and
osmolality and venous or arterial pH (see
Clinical Approach).
 MRI (after rapid correction of hyponatremia
and myelinolysis):2,3 Extrapontine lesions are
most common, especially lesions within the
thalamus. The lesions are described as nonen-
hancing, symmetrical increased signal intensi-
ADH = antidiuretic hormone;
BUN = blood urea nitrogen:
MRI = magnetic resonance
imaging; Na+ = sodium; SIADH
= syndrome of inappropriate
antidiuretic hormone secretion
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Table 1. Regulation of Body Fluid Balance
Water Balance Na+ Balance (Volume Regulation)  
Signal Plasma osmolality Effective circulating volume  
Sensors Hypothalamic osmoreceptors • Baroreceptors of the aorta, carotid sinus, and
afferent glomerular arteriole
• Atrial distension  
Effectors Antidiuretic hormone • Sympathetic nervous system
• Renin-angiotensin aldosterone system
• Atrial natriuretic peptide
• Antidiuretic hormone
• Pressure natriuresis  
Response • Water excretion (via antidiuretic Na+ excretion
hormone)
• Water intake (via thirst) 
ties on T2-weighted scans, which represent an
increase in water density associated with
inflammation, gliosis, edema, or necrosis.
Central nervous system lesions may not
always be visible on MRI early in the course
of neurologic disease.
Clinical Approach
If the cause of hyponatremia is not readily appar-
ent (also see Diagnostic Tree: Hyponatremia,
page 55):
 Evaluate blood sample for lipemia and meas-
ure plasma protein concentration to rule out
pseudohyponatremia. Lipemia and hyperpro-
teinemia underestimate Na+ concentration
when flame photometry is used, but this does
not happen with ion-selective electrode tech-
niques. Plasma osmolality is normal because
lipids and proteins contribute little to plasma
osmolality. 
 Measure glucose concentration to rule out
translocational hyponatremia. The following
formula can be used to correct sodium in the
presence of hyperglycemia:
Corrected Na+ = Measured Na+ + 
1.6 [(Serum glucose - 100)/100]
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 Measure or calculate Posm, other electrolytes,
and urea concentrations with or without pH: 
 Posm < 290 mOsm/kg confirms hypoosmo-
lality. However, increased BUN may cause
plasma osmolality to be normal or high
while the effective osmolality is reduced.
 Metabolic alkalosis and hypokalemia sug-
gest vomiting or diuretic use.
 Metabolic acidosis and hyperkalemia sug-
gest Addison’s disease or gastrointestinal
disease (eg, trichuriasis) when renal func-
tion is normal.
 Measure urine osmolality (Uosm) to determine
whether water excretion is normal or impaired.
The normal response to hyponatremia is to
suppress ADH secretion, resulting in maxi-
mally dilute urine (< 100 mOsm/kg or urine
specific gravity < 1.003). 
 Hyponatremia with Posm and Uosm
< 100 mOsm/kg (ADH suppression) 
suggests primary polydipsia.
 Measure urine Na+ concentration (Una) to
differentiate volume depletion and SIADH
when urine osmolality is high. 
 Una should be < 20 mEq/L with hypovolemia.
 Una should be > 20 mEq/L with Addison’s
disease, diuretic therapy, or SIADH. While
SIADH is a common cause of hypona-
tremia in humans, it is rarely described in
veterinary patients.
 Perform a fecal examination to rule out gas-
trointestinal parasitism.4
 Consider an ACTH stimulation test to rule
out Addison’s disease. Hypoadrenocorticism
leads to urinary loss of sodium chloride, vol-
ume depletion, and ADH release. As many as
81% of dogs with hypoadrenocorticism are
hyponatremic at presentation.5
 Consider measurement of T4 and/or TSH.
Myxedema coma due to hypothyroidism may
cause hyponatremia in people and dogs, possi-
bly because of ADH release secondary to
decreased cardiac output and decreased
glomerular filtration rate (rare).6,7
TREATMENT
Inpatient or Outpatient
 Patients with neurologic signs or severe
hyponatremia should be treated in an inten-
sive care unit.
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 Volume-depleted patients require inpatient
management with IV fluids.
 Normovolemic or edematous patients may be
able to be managed as outpatients.
Medical
 Two basic goals of therapy for hyponatremia:
 Treat underlying cause
 Increase plasma Na+ concentration at a safe
rate
 In general, hyponatremia is corrected by giv-
ing Na+ to patients who have extracellular
fluid volume depletion and by restricting
sodium in patients who are hyponatremic but
normovolemic or edematous (eg, sodium-
retaining states, such as congestive heart fail-
ure, cirrhosis, and nephrotic syndrome). 
Rate of Correction 
 Ideally, the rate of correction should be similar
to that at which hyponatremia developed. For
example, acute (< 24–48 hours’ duration)
hyponatremia with clinical signs should be
treated aggressively to reverse cerebral edema.
However, most patients develop hyponatremia
over 2 or more days (chronic hyponatremia), a
situation in which the brain has had time to
adapt to hypoosmolarity. Under these circum-
stances a conservative approach of no more
than 0.5 mEq/L per hour or 10 mEq/L per
day of sodium replacement is generally recom-
mended to avoid rapid correction of
sodium.1,2,6 
 Rapid correction of chronic hyponatremia
(generally > 15 mEq Na/L per day) can lead
to a neurologic disorder called demyelinating
encephalopathy, or myelinolysis. The mecha-
nism is not clear, but brain cells adapted to
hyponatremia may be at particular risk. Clini-
cal signs typically develop 3 to 4 days after
correction of hyponatremia and are character-
ized by paraparesis or tetraparesis, dysphagia,
coma, and seizures.1–3
 In correcting severe hyponatremia, formulas
may be helpful, but serum Na+ concentrations
should be measured frequently (eg, every 3–6
hours) and therapy adjusted accordingly. 
 Conventional crystalloid solutions are gener-
ally recommended for correcting hypovolemic
hyponatremic patients. Table 2 provides the
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FIND MORE
A case study
addressing 
treatment for
hyponatremia 
in a dog with
lethargy, 
vomiting, and
diarrhea can 
be viewed at 
>>Go to Journal
Extras on our
homepage.
cliniciansbrief.com
at cliniciansbrief.com). Therapy is then
adjusted on the basis of serial serum Na+
concentrations.
IN GENERAL
Relative Cost
The cost of investigating and treating hypona-
tremia depends on the cause and severity. If the
patient has no clinical signs and underlying dis-
ease is treatable, the treatment may be relatively
inexpensive ($$–$$$$). However, if the patient is
showing neurologic signs, has severe hypona-
tremia, or needs intensive care because of the
underlying disease process, the cost will be much
higher ($$$$$). 
Prognosis & Course
Outcome depends on the cause of hyponatremia
and the presence of neurologic signs. Many
patients without clinical signs have an excellent
prognosis, whereas patients with acute severe
hyponatremia that display neurologic signs
(either before or during treatment) will have a
prognosis from good to guarded.
See Aids & Resources, back page, for references
and suggested reading.
main composition of several crystalloid fluids.
 The degree to which a given fluid will
increase serum Na+ can be estimated by using
the following formula (infusate Na+ = Na+
concentration of the corrective fluid):
∆ Serum Na+ = 
Infusate Na+ – Serum Na+/TBW + 1
 The amount of sodium required (sodium
deficit) can also be estimated by using the 
following formula:
∆ Na+ deficit = TBW × (desired Na+ – actual Na+)
 Unfortunately, the above formulas are only
estimates and do not account for the effect of
concurrent potassium administration (which
will increase serum Na+ because of extracellu-
lar movement), the effect volume replacement
has on ADH secretion, or ongoing fluid
losses. 
 In general, for most patients with chronic
hyponatremia and hypovolemia, the initial
fluid type and volume administered are based
on the severity of hyponatremia, degree of
volume depletion, estimated ongoing losses,
and maintenance fluids; the goal is a Na+ cor-
rection rate less than 0.5 mEq/kg per hour. At
our institution, this usually results in the con-
current administration of maintenance (hypo-
tonic) and replacement (relatively isotonic)
crystalloid solutions (Case Study available 
Table 2. Na+ Content & Main Composition of Various Crystalloid Fluids
Fluid Na+ Cl K Ca Mg Dextrose (%) Buffer Osmolality
7.5% NaCl 1283 1283 - - - - - 2567
0.9% NaCl 154 154 - - - - - 308
Normosol-R (hospira.com) 140 98 5 - 3 - 27 acetate 294
23 gluconate 
Lactated Ringer’s solution 130 109 4 3 - - 28 lactate 272
2.5% dextrose in 0.45% NaCl 77 77 - - - 2.5 - 280 
0.45%  NaCl 77 - - - - - 155  
Normosol-M (hospira.com) 40 40 13 - 3 5 16 acetate 364  
Dextrose 5% (D5W) - - - - - 5 - 253
Ions & buffers are expressed as mEq/L; osmolality is expressed as mOsmol/L
Ca = calcium; Cl = chloride; k = potassium; Mg = magnesium; Na+ = sodium 
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Cost Key
$ = < $100 
$$ = $100–$250 
$$$ = $250–$500
$$$$ = $500–$1000
$$$$$ = > $1000
ACTH = adrenocorticotropic hormone; ADH = antidiuretic hormone; BUN = blood urea nitrogen; Na+ = sodium; Posm = plasma 
osmolality; SIADH = syndrome of inappropriate antidiuretic hormone secretion; T4 = thyroxine; TBW = total body weight; 
TSH = thyroid-stimulating hormone; Una = urine concentration; Uosm = urine osmolality
